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Exploration of non-coding genome has recently uncovered a growing list of formerly
unknown regulatory long non-coding RNAs (lncRNAs) with important functions in stem
cell pluripotency, development and homeostasis of several tissues. Although thousands
of lncRNAs are expressed in mammalian brain in a highly patterned manner, their roles in
brain development have just begun to emerge. Recent data suggest key roles for these
molecules in gene regulatory networks controlling neuronal and glial cell differentiation.
Analysis of the genomic distribution of genes encoding for lncRNAs indicates a physical
association of these regulatory RNAs with transcription factors (TFs) with well-established
roles in neural differentiation, suggesting that lncRNAs and TFs may form coherent
regulatory networks with important functions in neural stem cells (NSCs). Additionally,
many studies show that lncRNAs are involved in the pathophysiology of brain-related
diseases/disorders. Here we discuss these observations and investigate the links between
lncRNAs, brain development and brain-related diseases. Understanding the functions of
lncRNAs in NSCs and brain organogenesis could revolutionize the basic principles of
developmental biology and neuroscience.
Keywords: non-coding genome, regulatory RNAs, gene regulatory networks, neural differentiation, neurogenesis,
gliogenesis, brain-related diseases
INTRODUCTION
A long standing question in biological sciences is how cell diver-
sity, specification patterns, and tissue complexity are generated
during organ development. The mammalian brain is the most
complex organ of any living organism. The question of how this
enormous complexity is generated is still open. Such complexity
is the result of millions of years of evolution that have equipped
neural stem/progenitor cells (NSCs/NPCs) in the embryo with
the ability to generate every neuron and glial cell in the brain via
a combined action of extrinsic morphogenetic cues and intrin-
sic gene regulatory networks. For long time, it was thought that
these networks are mainly based on cross-regulatory interactions
between transcription factors (TFs) (Jessell, 2000; Politis et al.,
2008; Kaltezioti et al., 2010; Martynoga et al., 2012; Stergiopoulos
and Politis, 2013). However, the recent advent of sequencing
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tein; RNA-Seq, RNA sequencing; RIP-Chip, RBP immunoprecipitation-microarray
(Chip); ChIRP, chromatin isolation by RNA precipitation; CHART, capture
hybridization analysis of RNA targets; CLIP, crosslinking-immunopurification;
UCSC, University of California Santa Cruz; ORFs, open reading frames; TFs, tran-
scription factors; HAR1, human accelerated region 1; AD, Alzheimer’s disease; HD,
Huntington’s disease; Dlx1AS, distal-less homeobox 1 antisense; Miat, myocardial
infarction associated transcript; Rmst, rhabdomyosarcoma 2 associated transcript;
Evf2, embryonic ventral forebrain 2; UtNgn1, untranslated neurogenin1; NEAT,
non-coding nuclear enriched abundant transcript.
methodologies and experimental data from large-scale consor-
tia focused on characterizing functional genomic elements such
as ENCODE and FANTOM, have revolutionized our view for
organization, activity, and regulation of the mammalian genome
(Carninci et al., 2005; Katayama et al., 2005; Birney et al., 2007).
Surprisingly, the vast majority of the genome is transcribed pro-
ducing not only protein-coding RNAs but also a vast number of
different kinds of newly-identified classes of non-coding RNAs,
including microRNAs (miRNAs-small non-coding RNAs) and
long non-coding RNAs (lncRNAs). miRNAs have been exten-
sively studied while the role of lncRNAs in cell biology together
with novel roles of miRNAs in directly regulating lncRNAs have
just begun to emerge (Amodio et al., 2012a,b; Rossi et al., 2013;
Tay et al., 2014). LncRNAs are transcribed by RNA polymerase II,
defined as endogenous cellular RNAs longer than 200 nt in length
that lack an ORF, can be post-transcriptional processed by 5′
capping, polyadenylation, splicing, RNA editing, and exhibit spe-
cific sub-cellular localization (Qureshi and Mehler, 2012). Most
importantly, it was recently shown that lncRNAs participate in
the gene regulatory networks controlling embryonic stem cell
(ESC) pluripotency andmetastasis of cancer cells, as well as devel-
opment and function of various tissues (Guttman et al., 2011;
Gutschner and Diederichs, 2012; Qureshi and Mehler, 2012; Yang
et al., 2013). Although lncRNAs are the most abundant classes
of RNAs (Katayama et al., 2005; Birney et al., 2007; Kapranov
et al., 2007b; Kapranov and St Laurent, 2012), they remain poorly
characterized and their roles in brain development have just
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begun to arise. Notably, it has been proposed that the number
of lncRNAs far exceeds the number of protein-coding mRNAs in
the mammalian transcriptome (Carninci et al., 2005; Kapranov
et al., 2010) and the vast majority of them appears to be expressed
in adult brain in a highly specific manner (Qureshi and Mehler,
2012).
In the last few years, many groups have focused their efforts
toward understanding the actions of lncRNAs in brain function
and evolution. In this mini-review, we highlight the emerging
evidence of the involvement of this new class of RNA molecules
in NSC biology during development and adulthood, in health
and disease. In particular, we summarize recent progress regard-
ing the participation of lncRNAs in the regulatory networks that
control the fine balance between proliferation and differentiation
decisions of NSCs. The ability of lncRNAs to interact with both
genomic loci and protein products of TF genes appears to endow
themwith a remarkable capacity to control NSCmaintenance and
differentiation, suggesting an undoubtedly important influence
on the pathophysiology of several neurodegenerative disorders
(Kapranov et al., 2007a,b; Guttman et al., 2009; Khalil et al., 2009;
Orom et al., 2010; Bian and Sun, 2011; Qureshi andMehler, 2012;
Spadaro and Bredy, 2012; Ng et al., 2013).
LncRNAs: NEW PLAYERS IN CELL BIOLOGY
LncRNAs can be classified as bidirectional, intronic, intergenic,
sense, antisense or 3′-UTR (untranslated region) transcripts with
respect to nearby protein-coding genes (Mercer et al., 2009;
Derrien et al., 2012). Some lncRNAs are exported from nucleus
and perform important functions in the cytoplasm, but more
often they are found in nucleus, particularly associated with
chromatin (Saxena and Carninci, 2011). In more detail, these
transcripts may be bound by proteins, other RNA molecules or
even fulfil intrinsic catalytic functions (Fedor and Williamson,
2005; Ye, 2007; Guttman and Rinn, 2012). The vast majority of
these transcripts are not translated, supporting a role as non-
coding RNAs rather than protein precursors (Banfai et al., 2012;
Derrien et al., 2012). Furthermore, lncRNAs are developmen-
tally regulated, expressed in specific cell types, associated with
chromatin signatures indicating transcriptional regulation, are
under evolutionary constraint and associated with carcinogene-
sis and other diseases; all of which support meaningful roles of
lncRNAs (Qureshi and Mehler, 2012; Fatica and Bozzoni, 2014).
LncRNAs also participate in a striking diversity of cellular pro-
cesses including transcriptional regulation, genomic imprinting,
alternative splicing, mRNA stability, translational control, DNA
damage response, cell cycle regulation and organelle biogenesis
(Rinn and Chang, 2012). Interestingly, it seems that knock-down
or over-expression of many of these lncRNAs produce pheno-
types that are very well correlated with their aberrant expression
in disease states (Qureshi et al., 2010; Gutschner and Diederichs,
2012; Qureshi and Mehler, 2012). Therefore, we believe that
lncRNA transcripts would eventually occupy a central place in our
understanding of the molecular mechanisms underlying human
diseases.
Systematical profiling and comprehensive annotation of lncR-
NAs in various cell types can shed light on the functionalities
of these novel regulators. LncRNA-protein interactions can be
currently predicted, approached and analyzed by various research
advanced tools and strategies apart from bioinformatics, includ-
ing high-throughput analysis of lncRNA expression [microar-
rays, RNA sequencing [RNA-Seq] (Mortazavi et al., 2008; Wang
et al., 2009; Ilott and Ponting, 2013), RNA CaptureSeq, iSeeRNA
[support vector machine (SVM)-based classifier] (Sun et al.,
2013), BRIC-Seq [50-bromo-uridine (BrU) immunoprecipita-
tion chase-deep sequencing analysis] (Imamachi et al., 2013)],
RIP [RNA-binding protein (RBP) immunoprecipitation] cou-
pled with microarray and high-throughput sequencing (RIP-
Chip/Seq respectively) (Zhao et al., 2010; Jain et al., 2011), ChIRP
(chromatin isolation by RNA purification) and CHART (cap-
ture hybridization analysis of RNA targets—High-throughput
finding of RBPs and DNAs) as well as CLIP (crosslinking-
immunopurification)-Seq, which provides transcriptome-wide
coverage for mapping RBP-binding sites (Khalil et al., 2009; Wu
et al., 2010; Chu et al., 2011; Zhu et al., 2013).
LncRNAs IN NEURAL STEM CELLS
These technologies have greatly helped the efforts to elucidate
the role of lncRNAs in NSCs, neural differentiation, migra-
tion and maturation. Toward this goal, Ramos and colleagues
identified and predicted regulatory roles for more than 12,000
novel lncRNAs (2,265 lncRNAs had proximal protein-coding
gene neighbors) in the subventricular zone (SVZ) of adult
mice. In FACS-sorted NSCs, they found a unique lncRNA
expression pattern for each of the three stages of neuro-
genesis analyzed. Moreover, by using ChIP-Seq (chromatin
immunoprecipitation-sequencing), lncRNAs were shown to be
transcriptionally regulated in a manner analogous to mRNAs,
enabling the prediction of lncRNAs that may function in the glial-
neuronal lineage specification of multipotent adult NSCs (Ramos
et al., 2013; Wang et al., 2013). Further transcriptome-next-
generation-sequencing revealed that lncRNA-mediated alter-
native splicing of cell fate determinants controls stem-cell
commitment during neurogenesis. Specifically, Aprea and co-
workers identified several genic and intergenic lncRNAs that
are functionally involved in neurogenic commitment, including
Cosl1, Btg2-AS1, Gm17566, Miat (Myocardial infarction asso-
ciated transcript-Gomafu), Rmst (Rhabdomyosarcoma 2 associ-
ated transcript), Gm17566, Gm14207, Gm16758, 2610307P16Rik,
AC102815.1, C230034O21Rik and 9930014A18Rik (Aprea et al.,
2013). Accordingly, subsequent studies using high-throughput
transcriptomic data (microarray platform) to examine lncRNA
differential expression in NSCs, GABAergic neurons and
oligodendrocytes, led to the identification of lncRNAs that
are dynamically regulated during neural lineage specifica-
tion, neuronal-glia fate switching and oligodendrocyte matu-
ration [i.e., Dlx1AS (Distal-less homeobox 1 antisense), Evf2
(Embryonic ventral forebrain 2), Rmst, utNgn1 (untranslated
Neurogenin1), MALAT1 (metastasis-associated lung adenocarci-
noma transcript 1; also named NEAT2)] (Mercer et al., 2010;
Qureshi and Mehler, 2012; Ng et al., 2013). ChIP-Seq approaches
were also developed to generate and investigate genome-wide
chromatin-state maps. These functional analyses predicted hypo-
thetical roles for 150 mammalian lincRNAs (long intergenic
non-coding RNAs) in a “guilt-by-association” manner in NSCs.
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FIGURE 1 | Proposed schematic models for the role of different lncRNAs
(green) in neural development. (A) LncRNA Dlx1AS consists of two exons
that are spliced and the mature transcript is polyadenylated. During neuronal
differentiation of adult SVZ NSCs, Dlx1AS is required for the induction of
Dlx1 and Dlx2 (red) gene expression (Gonzales-Roybal and Lim, 2013;
Ramos et al., 2013). (B) During neocortical neurogenesis, utNgn1 receive
Wnt signals (i.e., Wnt3a) to induce the expression of Neurog1 (red). PcG
protein-mediated mechanisms (i.e., Ring1B, H3K27me3, H3K4me3,
H3K9/K14ac) lead to the suppression of utNgn1 (Onoguchi et al., 2012).
(C) The overlapping regions of Nkx2.2AS and Nkx2.2 isoforms (I and II-red)
are necessary to promote Nkx2.2 mRNA levels and the subsequent
oligodendrocytic differentiation of NSCs (Tochitani and Hayashizaki, 2008).
(D) Mechanistic pathway for Evf2-dependent interactions crucial for
forebrain development. Secreted Shh (Sonic hedgehog) promotes
expression of Dlx1 and Dlx2 (red), which sequentially suppress Neuropilin2
and Notch signaling. Activation of Evf2 leads to the formation of a regulatory
network together with Dlx’s (red) and MECP2 (methyl CpG binding protein
2) that controls GAD67 and GABAergic-interneuron formation (Bond et al.,
2009). NSC, neural stem cell; Evf1 (lncRNA) (blue), Embryonic ventral
forebrain-1, Dlx6 antisense RNA 1 (Dlx6AS1).
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In particular, specific lincRNAs appeared to localize near genes
encoding key TFs (such as Sox2, Klf4, Myc, p53, NFkB and Brn1)
that are involved in processes ranging from hippocampal devel-
opment to neuronal and oligodendrocyte maturation (Guttman
et al., 2009; Qureshi and Mehler, 2012).
More concisely, Ramos et al. have also performed in vitro
knock-down studies and observed that Dlx1AS, a lncRNA
encoded from a bigene Dlx1/2 cluster, is associated with fate
determination of adult SVZ NSCs via positive regulation of Dlx1
and Dlx2 gene expression. Mechanistically, enhanced transcrip-
tion of Dlx1AS occurs during neurogenesis when H3K27me3
(trimethylation of histone H3 Lys-27) repression is decreased.
The H3K27me3-specific demethylase JMJD3 was also found to
be enriched at the Dlx1AS locus (Figure 1A) (Gonzales-Roybal
and Lim, 2013; Ramos et al., 2013). Recently, a comprehensive
study came up with the finding that UtNgn1 is a non-coding
RNA transcribed from an enhancer region of the Neurogenin1
(Neurog1) locus. This non-coding transcript seems to positively
regulate Neurog1 transcription during neuronal differentiation
of NSCs. In detail, during the late stage of neocortical NSC
development, utNgn1 expression is up-regulated via involve-
ment of Wnt signaling whereas it is down-regulated by PcG
(polycomb group) proteins (Figure 1B) (Onoguchi et al., 2012).
Additionally, two lncRNAs, nuclear enriched abundant tran-
scripts NEAT1 and NEAT2 (MALAT1) are up-regulated in neu-
ronal and glial progeny, and are associated with neuronal activity,
growth and branching (Mercer et al., 2010; Ng et al., 2013).
Miat (also called Gomafu) is one of the known non-coding
RNAs that participates in neuronal subtype- specific determi-
nation and is also highly expressed in oligodendrocyte lineage
specification (Aprea et al., 2013). In the same lineage, another
lncRNA, Nkx2.2AS, an antisense RNA of the known homeobox
TF Nkx2.2, appears to lead NSCs into oligodendrocytic fate
through modest induction of Nkx2.2 gene. By using deletion
mutants, Tochitani and Hayashizaki showed that the overlap-
ping regions of Nkx2.2AS and Nkx2.2 isoforms are required
for promoting Nkx2.2 mRNA levels and the subsequent oligo-
dendrocytic differentiation of NSCs (Figure 1C) (Tochitani and
Hayashizaki, 2008). Evf2 is predominantly detected in the devel-
oping forebrain, both in human and mouse, and is critical for
GABAergic-interneuron formation. Like other lncRNAs, Evf2
seems to control the expression of specific genes that are nec-
essary during brain development, such as Dlx5, Dlx6 and Gad1,
through distinct trans- and cis-acting mechanisms (Figure 1D)
(Bond et al., 2009). Interestingly, Rmst is presented to be a novel
marker for dopaminergic neurons during NSC differentiation,
where it is co-expressed with the midbrain-specific TF Lmx1a
(Uhde et al., 2010).
Considering the tight connection between pluripotency of
human ESCs and their differentiation into NSCs (ESC-derived
NSCs) and subsequently into neurons, Ng and co-workers exten-
sively showed that diverse lncRNAs are essential for ESC prolifer-
ation and neurogenesis through physical interaction with master
TFs (e.g., Sox2). In detail, microarray data analysis led to the
identification of 35 neuronal lncRNAs with important roles in
neuronal differentiation, e.g., Rmst (AK056164, AF429305 and
AF429306), lncRNA_N1 (AK124684), lncRNA_N2 (AK091713),
Table 1 | List of genes encoding TFs with critical roles in brain
development that also contain lncRNA genes in close proximity to
their genomic loci (<3,000bp).
Genes encoding for TFs LncRNAs Position
Ascl4 AK018959 Sense
Atoh7 AK005214 Sense
Crebbp 4930455F16Rik Intergenic
Crx CrxOS Bidirectional
Ctnnb1 4930593C16Rik Bidirectional
Cux2 AK006762 Sense
Cux2 AK187608 Bidirectional
Dlx1 Dlx1AS Antisense
Dlx4 A730090H04Rik Bidirectional
Dlx6 Dlx6AS1 Antisense
Dlx6 Dlx6AS2 Intronic
Emx2 Emx2OS Bidirectional
Evx1 5730457N03Rik Bidirectional
FezF1 FezF1-AS1 Bidirectional
FezF1 AK086573 Intergenic
FoxA2 AK156045 Antisense
FoxG1 AK158887 Intergenic
FoxG1 3110039M20Rik Sense
Gata1 S57880 Sense
Gata2 AK137172 Sense
Gata3 4930412013R Bidirectional
Gata4 AK031341 Intronic
Gata6 AK033147 Bidirectional
Gata6 AK003136 Bidirectional
Gbx2 D130058E05Rik Bidirectional
Gli1 AK157048 Sense
Gli2 AK054469 Intronic
Gli3 AK135998 Intergenic
Hmx1 E130018O15Rik Bidirectional
Irx2 Gm20554 Bidirectional
Lef1 Lef1-AS1 Bidirectional
Lhx1 Lhx1OS Bidirectional
Lhx3 AK035055 Bidirectional
Lhx8 AI606473 Bidirectional
Lmx1b C130021I20 Bidirectional
Lxrb (NR1H2) AK184603 3 ′-UTR
Meis1 AK144295 Antisense
Meis2 AK012325 Sense
Meis2 AK144367 Bidirectional
Meis2 AK144485 Bidirectional
Msx1 Msx1AS Antisense
MycN MYCNOS Bidirectional
Myt1L AK138505 Antisense
NFATc1 AK155068 3 ′-UTR
NFATc4 AK014164 Sense
NFIA E130114P18Rik Bidirectional
NFIB AK081607 Intronic
NFIx AK168184 Antisense
NFkB2 AK029443 Bidirectional
Ngn1 AK016084 Intergenic
(Continued)
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Table 1 | Continued
Genes encoding for TFs LncRNAs Position
Nkx2.2 Nkx2.2AS Antisense
Notch1 AK075572 Antisense
NR2F1 AK051417 Intergenic
NR2F1 A830082K12Rik Bidirectional
NR2F2 AK135306 Intronic
NR3C2 Gm10649 Bidirectional
NR4A2 BB557941 Intergenic
NR5A2 (lrh-1) AK178198 Antisense
NR5A2 (lrh-1) AK145521 Intronic
Otx2 Otx2OS Bidirectional
Pax2 AK006641 Antisense
Pax6 AK044354 Antisense
Pbx3 AK138624 Intronic
Pou4F1 AK084042 Intergenic
PPARd AK033897 Intronic
PPARd AK007468 Intronic
Prox1 AK142161 Bidirectional
Ptf1a AK053418 Antisense
RARa AK031732 Intronic
RARb AK052306 3 ′-UTR
RBPjK AK164362 Intronic
Runx1 AK131747 Intergenic
SATB2 9130024F11Rik Bidirectional
Six1 AK035085 3 ′-UTR
Six3 Six3OS1 Bidirectional
Six6 4930447C04Rik Bidirectional
Sox1 Gm5607 Sense
Sox10 GM10863 Bidirectional
Sox2 Sox2OT Sense
Sox21 AK039417 Bidirectional
Sox8 AK079380 Bidirectional
Sox9 BC006965 Bidirectional
STAT5b AK088966 Intronic
Tgif2 5430405H02Rik 3 ′-UTR
THRA AK165172 Intronic
THRB AK088911 Antisense
WT1 AK033304 Intronic
WT1 AI314831 Bidirectional
Zeb1 AK041408 Intronic
Zeb1 Gm10125 Bidirectional
Zeb2 Zeb2OS Bidirectional
Some of these TFs contain more than one lncRNA near to their genes (dupli-
cates). The position of each lncRNA relatively to its nearby protein-coding gene
is indicated at the third column of the table.
lncRNA_N3 (AK055040, etc.). They also suggested that these
lncRNAs are required for generation of neurons and suppres-
sion of gliogenesis by association with chromatin modifiers
and nuclear proteins (Ng et al., 2012). In agreement, another
study that aimed at identifying functional features of lncR-
NAs during ESC differentiation to adult cerebellum by utilizing
RNA-Seq and ChIP-Seq technologies, demonstrated that filtered
novel lncRNAs are located close to protein-coding genes involved
in functions such as neuronal differentiation and transcriptional
regulation (Guttman et al., 2009; Lv et al., 2013). Particular stud-
ies have been successful in identifying anti-NOS2A as an antisense
transcript of the NOS2A (Nitric oxide synthase 2 enzyme) gene,
an isoform of the NOS protein which induces hESC differentia-
tion into neurogenic precursors (Korneev et al., 2008). Specific
expression pattern was also detected for Otx2c (Orthodenticle
homeobox 2 c), an alternative splicing variant of the pre-mRNA
Otx2 with a possible role in neural differentiation of hESCs (Liu
et al., 2013). Another lncRNA that is correlated with the prolifer-
ation state of ESCs is lincRNA-Sox2, which is located at the pro-
moter of Sox2 locus and is regulated by Sox2 and Oct4 (Guttman
et al., 2009). Finally, a thorough targeted RNA-Seq analysis car-
ried out using neurons derived from patient-specific induced
pluripotent stem cells (iPSCs) showed that more than 1,500 lncR-
NAs are dynamically regulated during differentiation of iPSCs
toward glutamatergic neurons. Particularly, the expression of
1,622 non-coding genes (lncRNAs/lincRNAs) was dramatically
affected during conversion from iPSCs to differentiating neu-
rons, while alternative splicing occurred. Significant alterations
were also observed in the expression patterns of non-coding genes
involved in neuropsychiatric disorders (Lin et al., 2011; Qureshi
and Mehler, 2012; Akula et al., 2014).
LncRNAs IN BRAIN FUNCTION, EVOLUTION AND
NEUROLOGICAL DISEASES
The importance of lncRNAs in the brain is explicitly highlighted
by the observation that most of them are expressed in the adult
mammalian brain in highly regional-, cellular- and sub-cellular
compartment-specific and neuronal activity dependent profiles
(Mercer et al., 2008; Ponjavic et al., 2009; Qureshi and Mehler,
2012). In fact, it seems that lncRNAs have played important roles
in the evolution of the form and function of human brain, since
the fastest evolving regions of the primate genome are non-coding
sequences that generate lncRNAs implicated in the modulation
of neuro-developmental genes (Pollard et al., 2006; Qureshi and
Mehler, 2012). The most dramatic of these regions, called HAR1
(human accelerated region 1), is part of a novel lncRNA gene
(HAR1F) that is expressed specifically in Cajal–Retzius neurons
in the developing human neocortex from 7 to 19 gestational
weeks, a crucial period for cortical neuron-specification and
migration. Additionally, analysis of highly conserved lncRNAs in
birds, marsupials and eutherian mammals revealed a remarkable
similarity in spatiotemporal expression profiles of orthologous
lncRNAs, suggesting ancient roles during brain development
(Chodroff et al., 2010). Moreover, lncRNAs directly modulate
synaptic processes (MALAT1), protein synthesis (BC1), learning
and memory (Tsx), and are associated with neuronal activity in
mouse cortex (Qureshi and Mehler, 2012). In agreement with
these effects on neurons, lncRNAs have also been implicated in
the pathophysiology of neuro-developmental, neurodegenerative,
neuro-immunological and neuro-oncological diseases/disorders.
For instance, high levels of BC1/BC200 and BACE1-AS have
been implicated in Alzheimer’s disease (AD) while NEAT1’s
in Huntington’s disease (HD). BC1/BC200 normally seems to
selectively regulate local protein synthesis in post-synaptic den-
dritic compartments, by repressing translation via an elF4-A-
dependent mechanism (Qureshi et al., 2010; Niland et al., 2012).
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FIGURE 2 | RT-PCR-based detection of various lncRNAs associated with
CNS-related diseases or disorders. Experiments were performed using
cDNA samples derived from embryonic mouse brain (E15.5) or NSCs isolated
from embryonic mouse telencephalon and cultured ex vivo, as indicated. In
some cases alternative splicing isoforms are also evident. RT-PCR primer
sequences are available upon request.
De-regulation of BACE1-AS has been shown to be responsible for
feed-forward induction of BACE1 (β-secretase); thus leading to
amyloid β (Aβ) increased production and possible AD pathogene-
sis (Qureshi et al., 2010). Additionally,NEAT1 is a lncRNA known
to be involved in cell death mechanisms. In particular, NEAT1
controls target gene transcription by protein sequestration into
paraspeckles (stress-responsive sub-nuclear structures), a poten-
tially dysfunctional pathway in HD progression. In accordance,
Hirose and co-workers have very recently shown that NEAT1
transcriptional up-regulation leads to the enlargement of these
structures after proteasome inhibition (Johnson, 2012; Hirose
et al., 2014). Various lncRNAs have also been correlated with
Parkinson’s disease (PINK-AS1, UCHL1-AS1), amyotrophic lat-
eral sclerosis (MSUR1), Down’s syndrome (NRON) as well as
with tumor progression (ANRIL, MALAT1, HOTAIR, NOS3AS)
(Gutschner and Diederichs, 2012). A common theme emerg-
ing from all these cases is that lncRNAs control the expression
of nearby protein-coding genes in cis and de-regulation of this
relationship could lead to nervous system-related diseases. In
agreement, brain-expressed lncRNAs are preferentially located
adjacent to protein-coding genes that are also expressed in the
brain and involved in transcriptional regulation and/or nervous
system development (Mercer et al., 2008; Ponjavic et al., 2009).
Many of these pairs often exhibited coordinated expression dur-
ing developmental transitions. Therefore, it was suggested that
these lncRNAs may influence the expression of the associated
protein-coding genes similarly to previously characterized exam-
ples such as Nkx2.2AS, HOTAIR, p15AS, p21AS and Evf2.
PERSPECTIVE LINKS BETWEEN lncRNAs AND BRAIN
DEVELOPMENT
Over recent years, it has become more and more evident that
lncRNAs play key roles in gene regulatory networks controlling
nervous system development. To initially investigate this link,
we bioinformatically screened numerous mouse genes encod-
ing TFs with well-established roles in CNS (central nervous
system) development for close proximity with lncRNA genes
(based on publicly available data from UCSC genome-browser).
Accordingly, we managed to identify 79 such TF genes encom-
passing 91 transcriptional units for lncRNA genes in close prox-
imity (<3,000 base pairs-bp) (Table 1). In particular, 40.65% of
these lncRNAs are bidirectional, 16.48% intronic, 9.89% inter-
genic, 12.08% sense, 15.38% antisense and 5.49% 3′-UTR. The
majority of these lncRNAs have only been identified in genome-
wide expression screens, are expressed in nervous system, and
intriguingly, their functions are totally unknown. Some of them
have been reported to interact with TFs or chromatin-associated
complexes (Wang and Chang, 2011; Guttman and Rinn, 2012;
Rinn and Chang, 2012), indicating potential contribution to
the combinatorial transcriptional codes involved in NSC main-
tenance, sub-type/lineage specification and terminal differenti-
ation. Based on these preliminary evidence, we postulate that
lncRNAs and TFs with regulatory role in neurogenesis are inter-
connected and may form coherent cross-regulatory networks that
are associated with CNS development. However, this hypothesis
needs to be extensively interrogated in NSCs. Moreover, consider-
ing the fact that some TFs are used as reprogramming tools for the
production of iPSCs, induced neurons, induced NSCs, cardiomy-
ocytes, etc. (Yang et al., 2011), these lncRNAs may be utilized for
the production of clinically useful cell types in the near feature,
revolutionizing the basic principles of developmental/cell biology
as well as neuroscience.
To further examine the links between lncRNAs, brain devel-
opment and neurological disorders, we tested whether lncRNAs,
associated with nervous system-related diseases in humans, are
expressed in embryonic mouse brain (E15.5) or ex vivo cultured
NSCs (isolated from mouse telencephalon, E15.5). The ratio-
nal for these experiments was based on observations showing
many neurological diseases to be initiated very early during brain
maturation and development (Bian and Sun, 2011; Qureshi and
Mehler, 2012). Specifically, we first identified in silico and then
tested for expression 20 such lncRNAs with clear conservation
in mouse genome. Interestingly, RT-PCR (reverse transcription-
PCR) analysis revealed that most lncRNAs are expressed in both
brain and NSCs (Figure 2), suggesting potential involvement
in brain development. Moreover, a possible function of these
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lncRNAs in NSCs may contribute to their roles in neurological
diseases. Nevertheless, further investigation and initiation of new
experimental studies are needed to uncover the exact function of
lncRNAs in NSCs and nervous system in general.
CONCLUSIONS
LncRNAs represent a new exciting frontier in molecular biology
with major roles in NSC fate decisions, specification and com-
mitment. Full understanding of how these non-coding transcripts
regulate the expression of protein-coding genes and participate
in gene regulatory circuitries could lead to the discovery of novel
cellular/molecular mechanisms and signaling pathways involved
in neural development; thus having potential implications for the
treatment of nervous system-related diseases and traumas.
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